AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INSIG AI PLC

Director's Dealing Mar 8, 2022

7709_dirs_2022-03-08_d6711b84-d9a6-45c9-af10-73bcfbacea86.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9379D

Insig AI Plc

08 March 2022

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

8 March 2022 

Insig AI plc

("Insig AI" or the "Company")

Issue of Options and PDMR dealing

Insig AI plc (AIM: INSG), the data science and machine learning group, has agreed to issue Colm McVeigh, Chief Commercial Officer and a director of Insig AI  and certain employees with options over a total of 3,350,000 ordinary shares of 1 pence each in the capital of the Company (together, the "Options") with an exercise price of 48 pence (the "Exercise Price"). The Exercise Price represents a substantial premium of approximately 75% to the Company's closing share price of 27.5 pence on 7 March 2022. Due to the substantial premium of the Exercise Price, there are no financial performance metrics attached to the Options. The vesting of the Options is conditional on the continued employment of the option holder which also lapse should the option holder no longer be employed by the Company. A schedule of the Options granted is set out below:

Number of Options Vesting period
Colm McVeigh (PDMR) 2,000,000 4 October 2024 - 7 March 2032
Other employees 900,000 4 August 2024 - 7 March 2032
Other employees 150,000 4 January 2025 - 7 March 2032
Other employees 300,000 4 March 2025 - 7 March 2032

The granting of the Options to Colm McVeigh follows his appointment announcement on 10 November 2021.

For further information, please visit www.insg.ai or contact:  

Insig AI plc

Steve Cracknell (CEO)
Via SEC Newgate
Zeus Capital Limited (Nominated Adviser & Broker)

David Foreman / James Hornigold / Danny Philips
+44 (0) 20 3829 5000

SEC Newgate (Financial PR)                                                              +44 (0) 7540 106 366

Robin Tozer / Richard Bicknell                                                  [email protected]

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Colm McVeigh

2.

Reason for the notification

a)

Position/status:

Director

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Insig AI Plc

b)

LEI:

21380098CKBAG1NWCD98

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence

GB00BYV31355

b)

Nature of the transaction:

Grant of options over ordinary shares

c)

Price(s) and volume(s):

Price(s) Volume(s)
48 pence 2,000,000

d)

Aggregated information:

Aggregated volume:

Price:

Single transaction as in 4 c) above

Price(s) Volume(s)
48 pence 2,000,000

e)

Date of the transaction:

7 March 2022

f)

Place of the transaction:

Off-market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBDLLBLXLXBBZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.